Drug Delivery Systems Market Trends Supporting 7.2% CAGR Growth Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Drug Delivery Systems Market Set To Climb From $47.54 Billion In 2026 To $62.89 Billion By 2030
The drug delivery systems market has shown strong growth over recent years. It is projected to grow from $44.21 billion in 2025 to $47.54 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The historical expansion can be attributed to the widespread use of conventional oral and injectable delivery, limited biologics formulations, the development of hospital and clinical infrastructure, the rising prevalence of chronic diseases, and increasing research and development in pharmaceuticals.
The drug delivery systems market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $62.89 billion, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth during the forecast period can be attributed to several factors, including advancements in polymer and lipid-based delivery systems, the expansion of personalized medicine, the increasing application of inhalation and transmucosal delivery methods, the growing acceptance of homecare and self-administration devices, and the incorporation of digital monitoring and intelligent delivery technologies. Key trends expected within this period involve the increasing uptake of targeted and controlled drug release technologies, the expanding development of biologics and advanced therapeutics, the proliferation of homecare drug delivery solutions, the advancement of minimally invasive and needle-free delivery systems, and an elevated emphasis on patient compliance and safety.
Get A Free Sample Report With In-Depth Market Insights:
Drug Delivery Systems Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The rising occurrence of respiratory conditions is projected to drive the expansion of the drug delivery systems market in the future. Respiratory disorders are health issues that impede the normal functioning of the lungs and airways, leading to difficulty in breathing and reduced oxygen intake. The increase in these disorders is attributed to growing air pollution, which constantly exposes populations to toxic airborne particles and gases that impair lung function and contribute to the development and worsening of respiratory conditions. Drug delivery systems are essential for the effective treatment and management of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that medications reach the lungs directly, thereby enhancing therapeutic outcomes while minimizing systemic side effects. For instance, in March 2025, the UK Health Security Agency, a UK-based government agency, reported that in 2024, tuberculosis cases in England climbed by 13%, increasing to 5,480 cases from 4,850 cases in 2023. This escalating prevalence of respiratory disorders is therefore expected to boost the growth of the drug delivery systems market.
Drug Delivery Systems Market Segment Analysis And Revenue Potential
The drug delivery systems market covered in this report is segmented –
1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System
2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems
3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications
4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories
Subsegments:
1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors
2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations
3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays
4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery
Drug Delivery Systems Market Innovation Trends Shaping Future Development
Leading companies within the drug delivery systems market are concentrating on developing advanced solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. These metal-free, multidose nasal spray pumps are devices specifically engineered to dispense multiple doses of medication through the nasal passage without incorporating any metal components, thereby ensuring both safety and compatibility with various formulations. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity metal-free, multidose nasal spray pump. This particular nasal spray pump is designed for delivering nasal saline and other similar over-the-counter products, with a significant emphasis on its recyclability. It represents the first highly recyclable nasal spray pump from Aptar Pharma, having secured a Class AA certification from cyclos-HTP for European recycling systems. Being manufactured entirely from polyolefin materials and free from metal components or recycling contaminants, it aids in streamlining recycling efforts and improving the quality of recyclates. Leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump provides precise and consistent dosing with a gentle operation, without sacrificing ease of use or overall effectiveness.
Drug Delivery Systems Market Company Landscape And Competitive Strategy
Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB
View The Full Drug Delivery Systems Market Report:
Drug Delivery Systems Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
